Skip to main content

Andrea Vilaplana Blanes

I have a degree in Biochemistry and Biomedical Sciences from the University of Valencia. Currently, I work as a researcher in the Cancer and Hematological Diseases Research Group at VHIR. I am part of the personalized medicine program where we work every day to find new therapeutic and molecular targets and guide patients' treatment according to the molecular alterations of their tumors.

Institutions of which they are part

Administration and Management
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Andrea Vilaplana Blanes

Institutions of which they are part

Administration and Management
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

I have a degree in Biochemistry and Biomedical Sciences from the University of Valencia. Currently, I work as a researcher in the Cancer and Hematological Diseases Research Group at VHIR. I am part of the personalized medicine program where we work every day to find new therapeutic and molecular targets and guide patients' treatment according to the molecular alterations of their tumors.

I studied Biochemistry and Biomedical Sciences degree at the University of Valencia between 2015 and 2019. I arrived in Barcelona in 2019 to start the Master in Translational Research at VHIR together with the Autonomous University of Barcelona.

My professional experience is focused on childhood cancer research. In 2020 I started working as Data Manager / Data Entry in the Pediatric Oncology and Hematology Area of Vall d'Hebron Hospital. Currently, since March 2022, I am part of the Research Group on Childhood Cancer and Hematological Diseases at VHIR, developing research tasks as well as database and project management activities.

My research activity is focused on the search for new biomarkers and molecular alterations in childhood tumors, especially in a specific subtype of solid tumor called neuroblastoma.

Thanks to the incorporation to the group I am a part of numerous national and international projects and research organizations. I am sure that these will help to improve the quality of life and the chances of survival of our patients.

Projects

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, María de los Ángeles Rodríguez Sánchez, Uría Oficialdegui, Maria Luz, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Elisabet Megías Roda, Raquel Hladun Alvaro, Ariadna Boloix Amenós, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Júlia Sansa Girona, Gabriela Guillén Burrieza, Laura Alonso Garcia, Victoria Gutierrez Valle, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 30/06/2025

Implementation and new biomarker development for Personalised Medicine for Childhood Cancers in Spain

IP: Lucas Moreno Martín-Retortillo
Collaborators: Aroa Soriano Fernández, Marta Garrido Pontnou, Miguel Segura Ginard, Lorena Valero Arrese, Raquel Hladun Alvaro, Elena Antima Martinez Saez, Marta Sese Faustino, Gabriela Guillén Burrieza, Alba Fernández Gómez, Josep Roma Castanyer, Andrea Vilaplana Blanes, Sergio Manresa Vera, Paula Cabre Fernandez, Margarita Ortega Blanco, María Rosario Pérez- Torres Lobato, Asbleidy Carolina Torres Barbosa
Funding agency: Instituto de Salud Carlos III
Funding: 369260
Reference: PMP21/00073
Duration: 01/01/2022 - 31/12/2025

Next generation personalised medicine for childhood cancers

IP: Lucas Moreno Martín-Retortillo
Collaborators: Aroa Soriano Fernández, Jessica Camacho Soriano, Raquel Hladun Alvaro, Gabriela Guillén Burrieza, Andrea Vilaplana Blanes, Paula Cabre Fernandez, Lorena Valero Arrese, Sergio Manresa Vera, Mariona Morell Daniel
Funding agency: Instituto de Salud Carlos III
Funding: 214170
Reference: PI21/01661
Duration: 01/01/2022 - 31/12/2024

BEACON-BIO: deep biological characterisation and development of biomarkers for relapsed neuroblastoma

IP: Lucas Moreno Martín-Retortillo
Collaborators: Andrea Vilaplana Blanes, María Rosario Pérez- Torres Lobato
Funding agency: European Science Foundation
Funding: 104500
Reference: BEACON-BIO_FKC_2021
Duration: 01/01/2022 - 31/12/2023

Related news

"Generation of a bank of surgical orthotopic PDX (patient-derived xenografts) models within the framework of a personalized medicine program in pediatric cancer" was the awarded work, of the Childhood Cancer and Hematological Diseases Group of VHIR.

A study, co-led by Vall d’Hebron, has analysed the evolution of clinical trials with children and adolescents with cancer over the last 15 years, with the aim of optimising efficacy and defining lines for further progress.

The research team has shown that inhibiting the TRIB3 protein slows the growth of rhabdomyosarcoma and improves survival in animal models.

Related professionals

Vicente Descalzo Jorro

Vicente Descalzo Jorro

Infectious Diseases
Read more
Sebastian Corro  Ramis

Sebastian Corro Ramis

Reconstructive Surgery of the Locomotor System
Read more
Consuelo Garcia Carmona

Consuelo Garcia Carmona

Research technician
Peripheral Nervous System
Read more
Mª Eulàlia Joseph Munné

Mª Eulàlia Joseph Munné

Medium Grade Technician
General Services and Infrastructure
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.